The Joint Corp. (JYNT) 10-Q 11 Aug 17 2017 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2017	Aug. 04, 2017
Document Information [Line Items]
Entity Registrant Name	JOINT Corp
Entity Central Index Key	1,612,630
Trading Symbol	jynt
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		13,178,540
Document Type	10-Q
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2
Amendment Flag	false

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 3,046,777	$ 3,009,864
Restricted cash	280,414	334,394
Accounts receivable, net	1,135,574	1,021,733
Income taxes receivable	3,054	42,014
Notes receivable - current portion	53,475	40,826
Deferred franchise costs - current portion	516,981	748,300
Prepaid expenses and other current assets	557,246	499,525
Total current assets	5,593,521	5,696,656
Property and equipment, net	4,071,501	4,724,706
Notes receivable, net of current portion	148,525
Deferred franchise costs, net of current portion	887,900	836,350
Intangible assets, net	2,017,169	2,338,922
Goodwill	2,750,338	2,750,338
Deposits and other assets	657,202	707,889
Total assets	16,126,156	17,054,861
Current liabilities:
Accounts payable	971,326	1,054,946
Accrued expenses	267,425	299,997
Co-op funds liability	82,583	73,246
Payroll liabilities	609,544	750,421
Notes payable - current portion	100,000	331,500
Deferred rent - current portion	146,618	215,450
Deferred revenue - current portion	2,360,516	3,077,430
Other current liabilities	52,071	60,894
Total current liabilities	4,590,083	5,863,884
Revolving credit - notes payable	1,000,000
Deferred rent, net of current portion	875,845	1,400,790
Deferred revenue, net of current portion	3,876,388	2,231,712
Deferred tax liability	176,032	120,700
Other liabilities	1,030,003	512,362
Total liabilities	11,548,351	10,129,448
Commitments and contingencies
Stockholders' equity:
Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of June 30, 2017 and December 31, 2016
Common stock, $0.001 par value; 20,000,000 shares authorized, 13,461,044 shares issued and 13,164,540 shares outstanding as of June 30, 2017 and 13,317,393 shares issued and 13,020,889 outstanding as of December 31, 2016	13,461	13,317
Additional paid-in capital	36,709,063	36,398,588
Treasury stock, at cost, 296,504 shares as of June 30, 2017 and December 31, 2016	(503,118)	(503,118)
Accumulated deficit	(31,641,601)	(28,983,374)
Total stockholders' equity	4,577,805	6,925,413
Total liabilities and stockholders' equity	$ 16,126,156	$ 17,054,861

Consolidated Balance Sheets (C3

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Jun. 30, 2017	Dec. 31, 2016
Series A preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Series A preferred stock, shares authorized (in shares)	50,000	50,000
Series A preferred stock, shares issued (in shares)	0	0
Series A preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	13,461,044	13,317,393
Common stock, shares outstanding (in shares)	13,164,540	13,020,889
Treasury stock, shares (in shares)	296,504	296,504

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenues:
Revenues and management fees from company clinics	$ 2,707,458	$ 2,137,252	$ 5,223,059	$ 3,795,805
Royalty fees	1,854,087	1,428,548	3,560,160	2,797,379
Franchise fees	357,600	524,209	807,100	1,039,009
Advertising fund revenue	621,578	356,580	1,220,014	622,301
IT related income and software fees	282,525	229,400	549,538	450,534
Regional developer fees	119,733	225,080	196,629	372,617
Other revenues	71,827	72,972	132,165	161,432
Total revenues	6,014,808	4,974,041	11,688,665	9,239,077
Cost of revenues:
Franchise cost of revenues	704,767	668,851	1,388,010	1,363,586
IT cost of revenues	65,452	58,888	124,313	104,116
Total cost of revenues	770,219	727,739	1,512,323	1,467,702
Selling and marketing expenses	1,058,224	1,174,178	2,016,930	1,912,861
Depreciation and amortization	503,226	637,115	1,081,212	1,212,659
General and administrative expenses	4,667,688	5,621,771	9,231,768	11,313,826
Total selling, general and administrative expenses	6,229,138	7,433,064	12,329,910	14,439,346
Loss on disposition or impairment			417,971
Loss from operations	(984,549)	(3,186,762)	(2,571,539)	(6,667,971)
Other (expense) income, net	(24,030)	(1,150)	(43,496)	(677)
Loss before income tax expense	(1,008,579)	(3,187,912)	(2,615,035)	(6,668,648)
Income tax expense	(2,583)	(73,470)	(43,192)	(117,867)
Net loss and comprehensive loss	$ (1,011,162)	$ (3,261,382)	$ (2,658,227)	$ (6,786,515)
Loss per share:
Basic and diluted loss per share (in dollars per share)	$ (0.08)	$ (0.26)	$ (0.20)	$ (0.54)
Basic and diluted weighted average shares (in shares)	13,127,255	12,672,974	13,085,159	12,620,438

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (2,658,227)	$ (6,786,515)
Adjustments to reconcile net loss to net cash used in operating activities:
(Recovery) provision for bad debts		(10,830)
Regional developer fees recognized upon acquisition of development rights		(138,500)
Net franchise fees recognized upon termination of franchise agreements	(31,200)	(184,159)
Depreciation and amortization	1,081,212	1,212,659
Loss on disposition or impairment	417,971
Deferred income taxes	55,332
Stock based compensation expense	227,121	757,394
Changes in operating assets and liabilities:
Restricted cash	53,980	(179,893)
Accounts receivable	(161,302)	(1,053,714)
Income taxes receivable	38,960	32,167
Prepaid expenses and other current assets	(57,721)	6,338
Deferred franchise costs	164,469	211,650
Deposits and other assets	50,687	12,637
Accounts payable	(83,620)	(1,120,615)
Accrued expenses	(32,572)	(268,436)
Co-op funds liability	9,337	(96,715)
Payroll liabilities	(140,877)	(954,687)
Other liabilities	(112,278)	44,826
Deferred rent	(343,191)	877,156
Deferred revenue	787,262	(416,001)
Net cash used in operating activities	(734,657)	(8,055,238)
Cash flows from investing activities:
Cash paid for acquisitions		(811,451)
Reacquisition and termination of regional developer rights		(325,000)
Purchase of property and equipment	(106,254)	(1,341,402)
Payments received on notes receivable	25,826	11,904
Net cash used in investing activities	(80,428)	(2,465,949)
Cash flows from financing activities:
Borrowings on revolving credit note payable	1,000,000
Issuance of common stock, offering costs adjustment		(1,042)
Proceeds from exercise of stock options	83,498	65,592
Repayments on notes payable	(231,500)	(217,450)
Net cash provided by (used in) financing activities	851,998	(152,900)
Net increase (decrease) in cash	36,913	(10,674,087)
Cash at beginning of period	3,009,864	16,792,850
Cash at end of period	$ 3,046,777	$ 6,118,763

Supplemental Disclosure of Non-

Supplemental Disclosure of Non-cash Activity	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Cash Flow, Supplemental Disclosures [Text Block]	During the six June 30, 2017 2016, $22,838 $0, six June 30, 2017 2016, $56,993 $3,550, Supplemental disclosure of non-cash activity: As of June 30, 2016, $258,696 In connection with our acquisitions of franchises during the six June 30, 2016, $296,571 $294,772, $478,326 $72,218 $839,000 $186,000. $29,000, $1,450, 2 In connection with our reacquisition and termination of regional developer rights during the six June 30, 2016, $224,750, 952 605, 2 In connection with our sale of the regional developer territory in Central Florida, we issued a note receivable in the amount of $187,000

Note 1 - Nature of Operations a

Note 1 - Nature of Operations and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	Note 1: Basis of Presentation These unaudited financial statements represent the condensed consolidated financial statements of The Joint Corp. (“The Joint”) and its wholly owned subsidiary The Joint Corporate Unit No. 1, 10 June 30, 2017 2016 not June 30, 2017 2016 Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. 1, All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from general and administrative expenses to other (expense) income, net for the three six June 30, 2016 Comprehensive Loss Net loss and comprehensive loss are the same for the three six June 30, 2017 2016. Nature of Operations The Joint, a Delaware corporation, was formed on March 10, 2010 The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed clinics for the three six June 30, 2017 2016: Three Months Ended Six Months Ended Franchised clinics: 2017 2016 2017 2016 Clinics open at beginning of period 326 277 309 265 Opened or purchased during the period 11 11 29 25 Acquired during the period - (6 ) - (6 ) Closed during the period (1 ) (2 ) (2 ) (4 ) Clinics in operation at the end of the period 336 280 336 280 Three Months Ended Six Months Ended Company-owned or managed clinics: 2017 2016 2017 2016 Clinics open at beginning of period 47 54 61 47 Opened during the period - 1 - 8 Acquired during the period - 6 - 6 Closed or sold during the period - - (14 ) - Clinics in operation at the end of the period 47 61 47 61 Total clinics in operation at the end of the period 383 341 383 341 Clinics licenses sold but not yet developed 109 134 109 134 Variable Interest Entities An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a variable interest entity (“VIE”) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not not Certain states in which the Company manages clinics regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with such PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice. The Company has analyzed its relationship with the PCs and has determined that the Company does not not Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three no June 30, 2017 December 31, 2016. Restricted Cash Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to the Company’s National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Company’s Franchise Disclosure Document with a focus on regional and national marketing and advertising. Concentrations of Credit Risk From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of June 30, 2017, December 31, 2016, three five 21% 24%, not 10% three six June 30, 2017 2016. Accounts Receivable Accounts receivable represent amounts due from franchisees for initial franchise fees and royalty fees, working capital advances due from PCs, and tenant improvement allowances due from landlords. The Company considers a reserve for doubtful accounts based on the creditworthiness of the entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management’s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. Actual losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of June 30, 2017, December 31, 2016, $131,830. Deferred Franchise Costs Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are recognized as an expense when the respective revenue is recognized, which is generally upon the opening of a clinic. Property and Equipment Property and equipment are stated at cost or for property acquired as part of franchise acquisitions at fair value at the date of closing. Depreciation is computed using the straight-line method over estimated useful lives of three seven Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income. Software Developed The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally five Intangible Assets Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships. The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from six eight seven two Goodwill Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions. Goodwill and intangible assets deemed to have indefinite lives are not first fourth not No six June 30, 2017 2016. Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not not No six June 30, 2017 2016. Advertising Fund The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is 2% Co-Op Marketing Funds Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops’ officers. The marketing funds are included in restricted cash on the Company’s condensed consolidated balance sheets. Accounting for Costs Associated with Exit or Disposal Activities The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred. Costs to terminate an operating lease or other contracts are (a) costs to terminate the contract before the end of its term or (b) costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity is recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the fair value of the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows is recognized as an adjustment to the liability in the period of the change. As of June 30, 2017, $0.9 no Deferred Rent The Company leases office space for its corporate offices and company-owned or managed clinics under operating leases, which may Revenue Recognition The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics. Franchise Fees. ten no no Regional Developer Fees 2011, $7,250 25% 2017, $14,500 $19,950 3% For the six June 30, 2017, five $1.3 Revenues and Management Fees from Company Clinics. Royalties. 7% 2% two IT Related Income and Software Fees. Advertising Costs Advertising costs are expensed as incurred. Advertising expenses were $359,997 $646,411 three six June 30, 2017, $747,797 $1,169,895 three six June 30, 2016, Income Taxes The Company uses an estimated annual effective tax rate method in computing its interim tax provision. This effective tax rate is based on forecasted annual pre-tax income, permanent tax differences and statutory tax rates. Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment, amortization of goodwill, accounting for leases, and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not 50% At June 30, 2017 December 31, 2016, $8,000 $40,000, $1,000 $27,000, 2012 2013 Loss per Common Share Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock and stock options. Three Months Ended Six Months Ended 2017 2016 2017 2016 Net loss $ (1,011,162 ) $ (3,261,382 ) $ (2,658,227 ) $ (6,786,515 ) Weighted average common shares outstanding - basic 13,127,255 12,672,974 13,085,159 12,620,438 Effect of dilutive securities: Stock options - - - - Weighted average common shares outstanding - diluted 13,127,255 12,672,974 13,085,159 12,620,438 Basic and diluted loss per share $ (0.08 ) $ (0.26 ) $ (0.20 ) $ (0.54 ) The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive: Three Months Ended Six Months Ended 2017 2016 2017 2016 Unvested restricted stock 65,700 151,806 65,700 151,806 Stock options 1,044,286 787,955 1,044,286 787,955 Warrants 90,000 90,000 90,000 90,000 Stock-Based Compensation The Company accounts for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets and purchase price allocations. Recent Accounting Pronouncements In May 2014, No. 2014 09, Revenue from Contracts with Customers January 1, 2018. 2014 09 not 2014 09 606 606, second December 31, 2017. In February 2016, No. 2016 02, Leases (Topic 842 December 31, 2018. not In March 2016, 2016 09, Compensation—Stock Compensation (Topic 718 January 1, 2017. not In April 2016, No. 2016 10, Revenue from Contracts with Customers (Topic 606 two 606: 1 2 2014 09. In May 2016, No. 2016 12, Revenue from Contracts with Customers (Topic 606 no 2014 09. In August 2016, No. 2016 15, “Statement of Cash Flows (Topic 230 December 15, 2017. In November 2016, No. 2016 18, Statement of Cash Flows (Topic 230 December 15, 2017, In January 2017, No. 2017 01, Business Combinations (Topic 805 December 15, 2017, In January 2017, 2017 04, Intangibles - Goodwill and Other (Topic 350 2” December 15, 2019. In May 2017, No. 2017 09, “Compensation—Stock Compensation (Topic 718 1 2 718, 718.The December 15, 2017,

Note 2 - Acquisitions

Note 2 - Acquisitions	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Business Combination Disclosure [Text Block]	Note 2: Franchises acquired during 2016 During the six June 30, 2016, six one $1,025,000, $839,000 $186,000. six a deferred revenue balance of $29,000, $1,450, $997,451 The Company incurred approximately $49,000 six June 30, 2016 Purchase Price Allocation The following summarizes the aggregate estimated fair values of the assets acquired and liabilities assumed during 2016 Property and equipment $ 296,571 Intangible assets 294,772 Goodwill 478,326 Total assets acquired 1,069,669 Deferred membership revenue (72,218 ) Net assets acquired 997,451 Net purchase price $ 997,451 Intangible assets in the table above consist of reacquired franchise rights of $201,409 $93,363, six eight two Goodwill recorded in connection with these acquisitions was attributable to the workforce of the clinics and synergies expected to arise from cost savings opportunities. All of the recorded goodwill is tax-deductible. Pro Forma Results of Operations (Unaudited) The following table summarizes selected unaudited pro forma condensed consolidated statements of operations data for the three six June 30, 2017 2016 2016 January 1, 2016. Pro Forma for the Three Months Ended Pro Forma for the Six Months Ended June 30, 2017 June 30, 2016 June 30, 2017 June 30, 2016 Revenues, net - $ 4,954,003 - $ 9,219,436 Net loss - $ (3,224,469 ) - $ (6,728,596 ) This selected unaudited pro forma condensed consolidated financial data is included only for the purpose of illustration and does not not 2016 2017 2016, three June 30, 2016 $1.9 $0.3 six June 30, 2016 $3.5 $0.4 The pro forma amounts included in the table above reflect the application of accounting policies and adjustment of the results of the clinics to reflect the additional depreciation and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets had been applied from January 1, 2016,

Note 3 - Notes Receivable

Note 3 - Notes Receivable	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 3: Effective July 2012, $90,000 6% fifty-four forty-two August 2013. January 2017 Effective July 2015, two $10,000 $29,925 24 September 1, 2015 August 1, 2017. Effective May 2016, three three $7,500 six May 1, 2017 October 1, 2017. Effective April 29, 2017, $320,000, $187,000 10% 42 36 November 1, 2017 October 1, 2020. The net outstanding balance of the notes as of June 30, 2017 December 31, 2016 $202,000 $40,826,

Note 4 - Property and Equipment

Note 4 - Property and Equipment	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 4: Property and equipment consists of the following: June 30, December 31, 2017 2016 Office and computer equipment $ 1,109,710 $ 1,083,039 Leasehold improvements 5,097,649 5,085,366 Software developed 1,048,697 891,192 7,256,056 7,059,597 Accumulated depreciation (3,324,119 ) (2,566,172 ) 3,931,937 4,493,425 Construction in progress 139,564 231,281 $ 4,071,501 $ 4,724,706 Depreciation expense was $356,329 $759,459 three six June 30, 2017, $462,233 $864,100 three six June 30, 2016, In December 2016, 14 December 2016, $2.4 2016 first 2017

Note 5 - Fair Value Considerati

Note 5 - Fair Value Consideration	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 5: The Company’s financial instruments include cash, restricted cash, accounts receivable, notes receivable, accounts payable, accrued expenses and notes payable. The carrying amounts of its financial instruments approximate their fair value due to their short maturities. The Company does not Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three Level 1: Observable inputs such as quoted prices in active markets; Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs in which there is little or no As of June 30, 2017, December 31, 2016, not 1, 2 3.

Note 6 - Intangible Assets

Note 6 - Intangible Assets	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	Note 6: Intangible assets consist of the following: As of June 30, 2017 Gross Carrying Accumulated Net Carrying Amortized intangible assets: Reacquired franchise rights $ 1,673,000 $ 534,316 $ 1,138,684 Customer relationships 701,000 624,167 76,833 Reacquired development rights 1,162,000 360,348 801,652 $ 3,536,000 $ 1,518,831 $ 2,017,169 As of December 31, 2016 Gross Carrying Accumulated Net Carrying Amortized intangible assets: Reacquired franchise rights $ 1,673,000 $ 410,688 $ 1,262,312 Customer relationships 701,000 509,042 191,958 Reacquired development rights 1,162,000 277,348 884,652 $ 3,536,000 $ 1,197,078 $ 2,338,922 Amortization expense was $146,897 $321,753 three six June 30, 2017, $174,882 $348,559 three six June 30, 2016, Estimated amortization expense for 2017 2017 (remaining) $ 257,128 2018 439,589 2019 413,256 2020 413,256 2021 348,034 Thereafter 145,906 Total $ 2,017,169

Note 7 - Debt

Note 7 - Debt	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 7: Notes Payable During 2015, 12 $800,350 1.5% 5.25% February 2017. During 2016, two $186,000 4.25% May 2017. Maturities of notes payable are as follows as of June 30, 2017: 2017 (remaining) $ 100,000 Thereafter - Total $ 100,000 Credit and Security Agreement On January 3, 2017, $5,000,000 10% $200,000. not $25,000. December 2019, June 30, 2017, $1,000,000 $5,000,000

Note 8 - Equity

Note 8 - Equity	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	Note 8: Stock Options In the six June 30, 2017, 190,286 $2.65 $3.88. Upon the completion of the Company’s IPO in November 2014, 10 The Company has computed the fair value of all options granted during the six June 30, 2017 2016, Six Months Ended June 30, 2017 2016 Expected volatility 42% 44% - 45% Expected dividends None None Expected term (years) 5.5 - 7 7 Risk-free rate 1.98% to 2.14% 1.47% to 1.68% Forfeiture rate 20% 2 0% The information below summarizes the stock options activity: Number of Weighted Weighted Weighted Outstanding at December 31, 2016 953,075 $ 3.66 $ 1.86 6.9 Granted at market price 190,286 3.69 Exercised (69,581 ) 1.20 Cancelled (29,494 ) 5.25 Outstanding at June 30, 2017 1,044,286 $ 3.78 $ 1.77 7.4 Exercisable at June 30, 2017 347,119 $ 4.54 $ 2.26 4.8 The intrinsic value of the Company’s stock options outstanding was $761,049 June 30, 2017. For the three six June 30, 2017, $84,845 $135,883, three six June 30, 2016, $171,152 $338,911, June 30, 2017 $835,077, 2.4 Restricted Stock The information below summaries the restricted stock activity: Restricted Stock Awards Shares Outstanding at December 31, 2016 92,415 Awards granted 59,700 Awards vested (74,070 ) Awards forfeited (12,345 ) Outstanding at June 30, 2017 65,700 For the three six June 30, 2017, $47,211 $91,238, three six June 30, 2016, $391,373 $418,483, June 30, 2017 $266,652 1.1 Treasury Stock In December 2013, first March 10, 2010 534,000 $0.45 $240,000 534,000 $791,638, 8 Year 1 $ 0.56 Year 2 $ 0.68 Year 3 $ 0.84 Year 4 $ 1.03 Year 5 $ 1.28 Year 6 $ 1.59 Year 7 $ 1.97 Year 8 $ 2.45 Consideration given in the form of the option was valued using a Binomial Lattice-Based model resulting in a fair value of $1.03 $551,638. During December 2016, 250,872 $210,000. $113,000 $259,000, $162,000.

Note 9 - Income Taxes

Note 9 - Income Taxes	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 9: For the three six June 30, 2017, $3,000 $43,000, For the three six June 30, 2016, $73,000 $118,000,

Note 10 - Related Party Transac

Note 10 - Related Party Transactions	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 10: The Company entered into consulting and legal agreements with certain common stockholders related to services performed for the operations and transaction related activities of the Company. Amounts paid to or for the benefit of these stockholders was approximately $61,000 $113,000 three six June 30, 2017, $118,000 $310,000 three six June 30, 2016,

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 11: Operating Leases The Company leases its corporate office space and the space for each of the company-owned or managed clinics in the portfolio. Total rent expense for the three six June 30, 2017 $681,792 $1,426,086, three six June 30, 2016 $854,516 $1,607,011, Future minimum annual lease payments are as follows: 2017 (remaining) $ 1,208,815 2018 1,880,961 2019 1,561,417 2020 1,289,964 2021 1,147,912 2022 1,039,682 Thereafter 2,890,000 Total $ 11,018,751

Note 12 - Segment Reporting

Note 12 - Segment Reporting	6 Months Ended
	Jun. 30, 2017
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	Note 12: An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (“CODM”) to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief Executive Officer. The Company has two June 30, 2017, 47 June 30, 2017, 336 two The tables below present financial information for the Company’s two Three Months Ended Six Months Ended 2017 2016 2017 2016 Revenues: Corporate clinics $ 2,680 $ 2,137 $ 5,176 $ 3,796 Franchise operations 3,335 2,837 6,513 5,443 Total revenues $ 6,015 $ 4,974 $ 11,689 $ 9,239 Segment operating income (loss): Corporate clinics $ (438 ) $ (1,647 ) $ (1,037 ) $ (3,336 ) Franchise operations 1,456 1,013 2,807 2,002 Total segment operating income (loss) $ 1,018 $ (634 ) $ 1,770 $ (1,334 ) Depreciation and amortization: Corporate clinics $ 400 $ 534 $ 843 $ 1,026 Franchise operations - - - - Corporate administration 103 103 238 187 Total depreciation and amortization $ 503 $ 637 $ 1,081 $ 1,213 Reconciliation of total segment operating income (loss) to consolidated earnings (loss) before income taxes: Total segment operating income (loss) $ 1,018 $ (634 ) $ 1,770 $ (1,334 ) Unallocated corporate (2,003 ) (2,553 ) (4,342 ) (5,334 ) Consolidated loss from operations (985 ) (3,187 ) (2,572 ) (6,668 ) Other (expense) income, net (24 ) (1 ) (43 ) (1 ) Loss before income tax expense $ (1,009 ) $ (3,188 ) $ (2,615 ) $ (6,669 ) June 30, December 31, Segment assets: Corporate clinics $ 9,705 $ 10,481 Franchise operations 1,907 2,003 Total segment assets $ 11,612 $ 12,484 Unallocated cash and cash equivalents and restricted cash $ 3,327 $ 3,344 Unallocated property and equipment 633 781 Other unallocated assets 554 446 Total assets $ 16,126 $ 17,055 “Unallocated cash and cash equivalents and restricted cash” relates primarily to corporate cash and cash equivalents and restricted cash (see Note 1 The Company reclassified approximately $545,000 December 31, 2016

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. 1, All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Certain balances were reclassified from general and administrative expenses to other (expense) income, net for the three six June 30, 2016
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Loss Net loss and comprehensive loss are the same for the three six June 30, 2017 2016.
Nature of Operations Policy [Policy Text Block]	Nature of Operations The Joint, a Delaware corporation, was formed on March 10, 2010 The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed clinics for the three six June 30, 2017 2016: Three Months Ended Six Months Ended Franchised clinics: 2017 2016 2017 2016 Clinics open at beginning of period 326 277 309 265 Opened or purchased during the period 11 11 29 25 Acquired during the period - (6 ) - (6 ) Closed during the period (1 ) (2 ) (2 ) (4 ) Clinics in operation at the end of the period 336 280 336 280 Three Months Ended Six Months Ended Company-owned or managed clinics: 2017 2016 2017 2016 Clinics open at beginning of period 47 54 61 47 Opened during the period - 1 - 8 Acquired during the period - 6 - 6 Closed or sold during the period - - (14 ) - Clinics in operation at the end of the period 47 61 47 61 Total clinics in operation at the end of the period 383 341 383 341 Clinics licenses sold but not yet developed 109 134 109 134
Consolidation, Variable Interest Entity, Policy [Policy Text Block]	Variable Interest Entities An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a variable interest entity (“VIE”) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not not Certain states in which the Company manages clinics regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with such PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice. The Company has analyzed its relationship with the PCs and has determined that the Company does not not
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three no June 30, 2017 December 31, 2016.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Restricted Cash Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to the Company’s National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Company’s Franchise Disclosure Document with a focus on regional and national marketing and advertising.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of June 30, 2017, December 31, 2016, three five 21% 24%, not 10% three six June 30, 2017 2016.
Trade and Other Accounts Receivable, Policy [Policy Text Block]	Accounts Receivable Accounts receivable represent amounts due from franchisees for initial franchise fees and royalty fees, working capital advances due from PCs, and tenant improvement allowances due from landlords. The Company considers a reserve for doubtful accounts based on the creditworthiness of the entity. The provision for uncollectible amounts is continually reviewed and adjusted to maintain the allowance at a level considered adequate to cover future losses. The allowance is management’s best estimate of uncollectible amounts and is determined based on specific identification and historical performance that the Company tracks on an ongoing basis. Actual losses ultimately could differ materially in the near term from the amounts estimated in determining the allowance. As of June 30, 2017, December 31, 2016, $131,830.
Revenue Recognition, Services, Commissions [Policy Text Block]	Deferred Franchise Costs Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are recognized as an expense when the respective revenue is recognized, which is generally upon the opening of a clinic.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost or for property acquired as part of franchise acquisitions at fair value at the date of closing. Depreciation is computed using the straight-line method over estimated useful lives of three seven Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.
Internal Use Software, Policy [Policy Text Block]	Software Developed The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight-line basis over its estimated useful life, generally five
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Intangible Assets Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships. The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from six eight seven two
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions. Goodwill and intangible assets deemed to have indefinite lives are not first fourth not No six June 30, 2017 2016.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not not No six June 30, 2017 2016.
Advertising Fund, Policy [Policy Text Block]	Advertising Fund The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is 2%
Cooperative Advertising Policy [Policy Text Block]	Co-Op Marketing Funds Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops’ officers. The marketing funds are included in restricted cash on the Company’s condensed consolidated balance sheets.
Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]	Accounting for Costs Associated with Exit or Disposal Activities The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred. Costs to terminate an operating lease or other contracts are (a) costs to terminate the contract before the end of its term or (b) costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity is recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the fair value of the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows is recognized as an adjustment to the liability in the period of the change. As of June 30, 2017, $0.9 no
Lessee, Leases [Policy Text Block]	Deferred Rent The Company leases office space for its corporate offices and company-owned or managed clinics under operating leases, which may
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.
Revenue Recognition, Services, Franchise Fees [Policy Text Block]	Franchise Fees. ten no no
Regional Developer Fees, Policy [Policy Text Block]	Regional Developer Fees 2011, $7,250 25% 2017, $14,500 $19,950 3% For the six June 30, 2017, five $1.3
Revenues and Management Fees, Policy [Policy Text Block]	Revenues and Management Fees from Company Clinics.
Royalties, Policy [Policy Text Block]	Royalties. 7% 2% two
IT Related Income And Software Fees, Policy [Policy Text Block]	IT Related Income and Software Fees.
Advertising Costs, Policy [Policy Text Block]	Advertising Costs Advertising costs are expensed as incurred. Advertising expenses were $359,997 $646,411 three six June 30, 2017, $747,797 $1,169,895 three six June 30, 2016,
Income Tax, Policy [Policy Text Block]	Income Taxes The Company uses an estimated annual effective tax rate method in computing its interim tax provision. This effective tax rate is based on forecasted annual pre-tax income, permanent tax differences and statutory tax rates. Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment, amortization of goodwill, accounting for leases, and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not 50% At June 30, 2017 December 31, 2016, $8,000 $40,000, $1,000 $27,000, 2012 2013
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock and stock options. Three Months Ended Six Months Ended 2017 2016 2017 2016 Net loss $ (1,011,162 ) $ (3,261,382 ) $ (2,658,227 ) $ (6,786,515 ) Weighted average common shares outstanding - basic 13,127,255 12,672,974 13,085,159 12,620,438 Effect of dilutive securities: Stock options - - - - Weighted average common shares outstanding - diluted 13,127,255 12,672,974 13,085,159 12,620,438 Basic and diluted loss per share $ (0.08 ) $ (0.26 ) $ (0.20 ) $ (0.54 ) The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive: Three Months Ended Six Months Ended 2017 2016 2017 2016 Unvested restricted stock 65,700 151,806 65,700 151,806 Stock options 1,044,286 787,955 1,044,286 787,955 Warrants 90,000 90,000 90,000 90,000
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation The Company accounts for share-based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets and purchase price allocations.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In May 2014, No. 2014 09, Revenue from Contracts with Customers January 1, 2018. 2014 09 not 2014 09 606 606, second December 31, 2017. In February 2016, No. 2016 02, Leases (Topic 842 December 31, 2018. not In March 2016, 2016 09, Compensation—Stock Compensation (Topic 718 January 1, 2017. not In April 2016, No. 2016 10, Revenue from Contracts with Customers (Topic 606 two 606: 1 2 2014 09. In May 2016, No. 2016 12, Revenue from Contracts with Customers (Topic 606 no 2014 09. In August 2016, No. 2016 15, “Statement of Cash Flows (Topic 230 December 15, 2017. In November 2016, No. 2016 18, Statement of Cash Flows (Topic 230 December 15, 2017, In January 2017, No. 2017 01, Business Combinations (Topic 805 December 15, 2017, In January 2017, 2017 04, Intangibles - Goodwill and Other (Topic 350 2” December 15, 2019. In May 2017, No. 2017 09, “Compensation—Stock Compensation (Topic 718 1 2 718, 718.The December 15, 2017,

Note 1 - Nature of Operations20

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Franchisor Disclosure [Table Text Block]	Three Months Ended Six Months Ended Franchised clinics: 2017 2016 2017 2016 Clinics open at beginning of period 326 277 309 265 Opened or purchased during the period 11 11 29 25 Acquired during the period - (6 ) - (6 ) Closed during the period (1 ) (2 ) (2 ) (4 ) Clinics in operation at the end of the period 336 280 336 280 Three Months Ended Six Months Ended Company-owned or managed clinics: 2017 2016 2017 2016 Clinics open at beginning of period 47 54 61 47 Opened during the period - 1 - 8 Acquired during the period - 6 - 6 Closed or sold during the period - - (14 ) - Clinics in operation at the end of the period 47 61 47 61 Total clinics in operation at the end of the period 383 341 383 341 Clinics licenses sold but not yet developed 109 134 109 134
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Six Months Ended 2017 2016 2017 2016 Net loss $ (1,011,162 ) $ (3,261,382 ) $ (2,658,227 ) $ (6,786,515 ) Weighted average common shares outstanding - basic 13,127,255 12,672,974 13,085,159 12,620,438 Effect of dilutive securities: Stock options - - - - Weighted average common shares outstanding - diluted 13,127,255 12,672,974 13,085,159 12,620,438 Basic and diluted loss per share $ (0.08 ) $ (0.26 ) $ (0.20 ) $ (0.54 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended Six Months Ended 2017 2016 2017 2016 Unvested restricted stock 65,700 151,806 65,700 151,806 Stock options 1,044,286 787,955 1,044,286 787,955 Warrants 90,000 90,000 90,000 90,000

Note 2 - Acquisitions (Tables)

Note 2 - Acquisitions (Tables)	6 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Property and equipment $ 296,571 Intangible assets 294,772 Goodwill 478,326 Total assets acquired 1,069,669 Deferred membership revenue (72,218 ) Net assets acquired 997,451 Net purchase price $ 997,451
Business Acquisition, Pro Forma Information [Table Text Block]	Pro Forma for the Three Months Ended Pro Forma for the Six Months Ended June 30, 2017 June 30, 2016 June 30, 2017 June 30, 2016 Revenues, net - $ 4,954,003 - $ 9,219,436 Net loss - $ (3,224,469 ) - $ (6,728,596 )

Note 4 - Property and Equipme22

Note 4 - Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2017
Notes Tables
Property, Plant and Equipment [Table Text Block]	June 30, December 31, 2017 2016 Office and computer equipment $ 1,109,710 $ 1,083,039 Leasehold improvements 5,097,649 5,085,366 Software developed 1,048,697 891,192 7,256,056 7,059,597 Accumulated depreciation (3,324,119 ) (2,566,172 ) 3,931,937 4,493,425 Construction in progress 139,564 231,281 $ 4,071,501 $ 4,724,706

Note 6 - Intangible Assets (Tab

Note 6 - Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Intangible Assets and Goodwill [Table Text Block]	As of June 30, 2017 Gross Carrying Accumulated Net Carrying Amortized intangible assets: Reacquired franchise rights $ 1,673,000 $ 534,316 $ 1,138,684 Customer relationships 701,000 624,167 76,833 Reacquired development rights 1,162,000 360,348 801,652 $ 3,536,000 $ 1,518,831 $ 2,017,169 As of December 31, 2016 Gross Carrying Accumulated Net Carrying Amortized intangible assets: Reacquired franchise rights $ 1,673,000 $ 410,688 $ 1,262,312 Customer relationships 701,000 509,042 191,958 Reacquired development rights 1,162,000 277,348 884,652 $ 3,536,000 $ 1,197,078 $ 2,338,922
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2017 (remaining) $ 257,128 2018 439,589 2019 413,256 2020 413,256 2021 348,034 Thereafter 145,906 Total $ 2,017,169

Note 7 - Debt (Tables)

Note 7 - Debt (Tables)	6 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Maturities of Long-term Debt [Table Text Block]	2017 (remaining) $ 100,000 Thereafter - Total $ 100,000

Note 8 - Equity (Tables)

Note 8 - Equity (Tables)	6 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Six Months Ended June 30, 2017 2016 Expected volatility 42% 44% - 45% Expected dividends None None Expected term (years) 5.5 - 7 7 Risk-free rate 1.98% to 2.14% 1.47% to 1.68% Forfeiture rate 20% 2 0%
Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of Weighted Weighted Weighted Outstanding at December 31, 2016 953,075 $ 3.66 $ 1.86 6.9 Granted at market price 190,286 3.69 Exercised (69,581 ) 1.20 Cancelled (29,494 ) 5.25 Outstanding at June 30, 2017 1,044,286 $ 3.78 $ 1.77 7.4 Exercisable at June 30, 2017 347,119 $ 4.54 $ 2.26 4.8
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	Restricted Stock Awards Shares Outstanding at December 31, 2016 92,415 Awards granted 59,700 Awards vested (74,070 ) Awards forfeited (12,345 ) Outstanding at June 30, 2017 65,700
Class of Treasury Stock [Table Text Block]	Year 1 $ 0.56 Year 2 $ 0.68 Year 3 $ 0.84 Year 4 $ 1.03 Year 5 $ 1.28 Year 6 $ 1.59 Year 7 $ 1.97 Year 8 $ 2.45

Note 11 - Commitments and Con26

Note 11 - Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	2017 (remaining) $ 1,208,815 2018 1,880,961 2019 1,561,417 2020 1,289,964 2021 1,147,912 2022 1,039,682 Thereafter 2,890,000 Total $ 11,018,751

Note 12 - Segment Reporting (Ta

Note 12 - Segment Reporting (Tables)	6 Months Ended
	Jun. 30, 2017
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended Six Months Ended 2017 2016 2017 2016 Revenues: Corporate clinics $ 2,680 $ 2,137 $ 5,176 $ 3,796 Franchise operations 3,335 2,837 6,513 5,443 Total revenues $ 6,015 $ 4,974 $ 11,689 $ 9,239 Segment operating income (loss): Corporate clinics $ (438 ) $ (1,647 ) $ (1,037 ) $ (3,336 ) Franchise operations 1,456 1,013 2,807 2,002 Total segment operating income (loss) $ 1,018 $ (634 ) $ 1,770 $ (1,334 ) Depreciation and amortization: Corporate clinics $ 400 $ 534 $ 843 $ 1,026 Franchise operations - - - - Corporate administration 103 103 238 187 Total depreciation and amortization $ 503 $ 637 $ 1,081 $ 1,213 Reconciliation of total segment operating income (loss) to consolidated earnings (loss) before income taxes: Total segment operating income (loss) $ 1,018 $ (634 ) $ 1,770 $ (1,334 ) Unallocated corporate (2,003 ) (2,553 ) (4,342 ) (5,334 ) Consolidated loss from operations (985 ) (3,187 ) (2,572 ) (6,668 ) Other (expense) income, net (24 ) (1 ) (43 ) (1 ) Loss before income tax expense $ (1,009 ) $ (3,188 ) $ (2,615 ) $ (6,669 )
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	June 30, December 31, Segment assets: Corporate clinics $ 9,705 $ 10,481 Franchise operations 1,907 2,003 Total segment assets $ 11,612 $ 12,484 Unallocated cash and cash equivalents and restricted cash $ 3,327 $ 3,344 Unallocated property and equipment 633 781 Other unallocated assets 554 446 Total assets $ 16,126 $ 17,055

Supplemental Disclosure of No28

Supplemental Disclosure of Non-cash Activity (Details Textual) - USD ($)	Apr. 29, 2017	Jun. 30, 2017	Jun. 30, 2016
Income Taxes Paid		$ 22,838	$ 0
Interest Paid		56,993	3,550
Payments to Acquire Businesses, Net of Cash Acquired			811,451
Deferred Revenue			224,750
Regional Developer Territory in Central Florida [Member]
Noncash or Part Noncash Divestiture, Amount of Consideration Received	$ 187,000
Franchise Fees [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment			296,571
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			294,772
Goodwill, Acquired During Period			478,326
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue			72,218
Payments to Acquire Businesses, Net of Cash Acquired			839,000
Business Combination, Consideration Transferred, Liabilities Incurred			186,000
Deferred Revenue			29,000
Deferred Franchise Costs Netted Against Aggregate Purchase Price			1,450
Accounts Payable [Member]
Capital Expenditures Incurred but Not yet Paid			$ 258,696

Note 1 - Nature of Operations29

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017USD ($)	Jun. 30, 2016USD ($)	Jun. 30, 2017USD ($)	Jun. 30, 2016USD ($)	Dec. 31, 2016USD ($)
Cash Equivalents, at Carrying Value	$ 0		$ 0		$ 0
Allowance for Doubtful Accounts Receivable	131,830		131,830
Goodwill, Impairment Loss			0	$ 0
Impairment of Long-Lived Assets Held-for-use			0	0
Lease Exit Liability	900,000		900,000
Regional Developers License Fee	7,250		$ 7,250
Regional Developers License Fee Current Franchise Fee Percentage			25.00%
Regional Developers Royalty Sales Generated by Franchises Percentage			3.00%
Deferred Revenue		$ 224,750		224,750
Franchise Royalty Gross Sales Percentage			7.00%
Franchise Monthly Marketing Fee Gross Sales Percentage			2.00%
Advertising Expense	359,997	$ 747,797	$ 646,411	$ 1,169,895
Liability for Uncertainty in Income Taxes, Current	8,000		8,000		40,000
Other Liabilities [Member]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	1,000		1,000		$ 27,000
Regional Development Agreement [Member]
Deferred Revenue	1,300,000		$ 1,300,000
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life			5 years
Development Rights [Member]
Finite-Lived Intangible Asset, Useful Life			7 years
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life			2 years
Minimum [Member]
Property, Plant and Equipment, Useful Life			3 years
Regional Developers, Franchise Fees Collected Upon Sale of Franchise	14,500		$ 14,500
Minimum [Member] | Franchise Rights [Member]
Finite-Lived Intangible Asset, Useful Life			6 years
Maximum [Member]
Property, Plant and Equipment, Useful Life			7 years
Regional Developers, Franchise Fees Collected Upon Sale of Franchise	$ 19,950		$ 19,950
Maximum [Member] | Franchise Rights [Member]
Finite-Lived Intangible Asset, Useful Life			8 years
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Three PC Entities [Member]
Number of PC Entities	3		3		3
Concentration Risk, Percentage			21.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Five Franchisees [Member]
Number of Franchises	5		5		5
Concentration Risk, Percentage					24.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Number of Major Customers	0	0	0	0

Note 1 - Nature of Operations30

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Clinics in operation at the end of the period	383	341	383	341
Number of Stores	383	341	383	341	383	341
Clinics licenses sold but not yet developed					109	134
Franchised Units [Member]
Clinics open at beginning of period	326	277	309	265
Opened or purchased during the period	11	11	29	25
Acquired during the period		(6)		(6)
Acquired during the period		6		6
Closed during the period	(1)	(2)	(2)	(4)
Clinics in operation at the end of the period	336	280	336	280
Number of Stores	326	277	309	265	336	280
Entity Operated Units [Member]
Clinics open at beginning of period	47	54	61	47
Opened or purchased during the period		1		8
Acquired during the period		(6)		(6)
Acquired during the period		6		6
Closed during the period			(14)
Clinics in operation at the end of the period	47	61	47	61
Number of Stores	47	54	61	47	47	61

Note 1 - Nature of Operations31

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Net loss	$ (1,011,162)	$ (3,261,382)	$ (2,658,227)	$ (6,786,515)
Weighted average common shares outstanding - basic (in shares)	13,127,255	12,672,974	13,085,159	12,620,438
Effect of dilutive securities:
Stock options (in shares)
Weighted average common shares outstanding - diluted (in shares)	13,127,255	12,672,974	13,085,159	12,620,438
Basic and diluted loss per share (in dollars per share)	$ (0.08)	$ (0.26)	$ (0.20)	$ (0.54)

Note 1 - Nature of Operations32

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Restricted Stock [Member]
Anti-dilutive Securities (in shares)	65,700	151,806	65,700	151,806
Employee Stock Option [Member]
Anti-dilutive Securities (in shares)	1,044,286	787,955	1,044,286	787,955
Warrant [Member]
Anti-dilutive Securities (in shares)	90,000	90,000	90,000	90,000

Note 2 - Acquisitions (Details

Note 2 - Acquisitions (Details Textual)	3 Months Ended	6 Months Ended
	Jun. 30, 2016USD ($)	Jun. 30, 2017	Jun. 30, 2016USD ($)
Deferred Revenue	$ 224,750		$ 224,750
Franchise Rights [Member] | Minimum [Member]
Finite-Lived Intangible Asset, Useful Life		6 years
Franchise Rights [Member] | Maximum [Member]
Finite-Lived Intangible Asset, Useful Life		8 years
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life		2 years
Reacquisitions of Franchises Throughout California and New Mexico [Member}
Number of Developed Franchises Reacquired During Period			6
Number of Undeveloped Franchises Reacquired During the Period			1
Business Combination, Consideration Transferred			$ 1,025,000
Payments to Acquire Businesses, Gross			839,000
Business Combination, Consideration Transferred, Liabilities Incurred			$ 186,000
Number of Reacquired Developed Franchises Operated as Company-owned or Managed Clinics	6		6
Deferred Revenue	$ 29,000		$ 29,000
Deferred Franchise Costs	1,450		1,450
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual	300,000		400,000
Business Combination, Consideration Transferred, Net of Deferred Revenue and Deferred Franchise Costs			997,451
Business Combination, Acquisition Related Costs			49,000
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual	$ 1,900,000		3,500,000
Reacquisitions of Franchises Throughout California and New Mexico [Member} | Franchise Rights [Member]
Finite-lived Intangible Assets Acquired			$ 201,409
Reacquisitions of Franchises Throughout California and New Mexico [Member} | Franchise Rights [Member] | Minimum [Member]
Finite-Lived Intangible Asset, Useful Life			6 years
Reacquisitions of Franchises Throughout California and New Mexico [Member} | Franchise Rights [Member] | Maximum [Member]
Finite-Lived Intangible Asset, Useful Life			8 years
Reacquisitions of Franchises Throughout California and New Mexico [Member} | Customer Relationships [Member]
Finite-lived Intangible Assets Acquired			$ 93,363
Finite-Lived Intangible Asset, Useful Life			2 years

Note 2 - Acquisitions - Purchas

Note 2 - Acquisitions - Purchase Price Allocation (Details) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2017	Dec. 31, 2016
Goodwill		$ 2,750,338	$ 2,750,338
Reacquisitions of Franchises Throughout California and New Mexico [Member}
Property and equipment	$ 296,571
Intangible assets	294,772
Goodwill	478,326
Total assets acquired	1,069,669
Deferred membership revenue	(72,218)
Net assets acquired	997,451
Net purchase price	$ 997,451

Note 2 - Acquisitions - Supplem

Note 2 - Acquisitions - Supplemental Pro Forma Information (Details) - The Joint RRC Corp [Member] - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenues, net		$ 4,954,003		$ 9,219,436
Net loss		$ (3,224,469)		$ (6,728,596)

Note 3 - Notes Receivable (Deta

Note 3 - Notes Receivable (Details Textual)	Apr. 29, 2017USD ($)	May 31, 2016USD ($)	Jul. 31, 2015USD ($)	Jul. 31, 2012USD ($)	Jun. 30, 2017USD ($)	Dec. 31, 2016USD ($)
Regional Development Agreement	$ 320,000
Non-interest Bearing Unsecured Promissory Note 1 [Member]
Financing Receivable, Net			$ 10,000
Non-interest Bearing Unsecured Promissory Note 2 [Member]
Notes Receivable, Contractual Term			2 years
Financing Receivable, Net			$ 29,925
Non-interest Bearing Unsecured Promissory Note Maturing October 1, 2017 [Member]
Notes Receivable, Contractual Term		180 days
Number of License Transfer Agreements		3
Number of Unsecured Promissory Notes		3
Financing Receivable, Net		$ 7,500
10% Interest Bearing Promissory Note Maturing October 1, 2020 [Member]
Notes Receivable, Contractual Term	3 years 180 days
Notes Receivable, Principal and Interest, Term	3 years
Financing Receivable, Net	$ 187,000
Notes Receivable, Interest Rate	10.00%
Company-owned Clinic [Member]
Notes Receivable, Contractual Term				4 years 180 days
Notes Receivable, Principal and Interest, Term				3 years 180 days
Number of License Transfer Agreements			2
Financing Receivable, Net				$ 90,000	$ 202,000	$ 40,826
Notes Receivable, Interest Rate				6.00%

Note 4 - Property and Equipme37

Note 4 - Property and Equipment (Details Textual)	1 Months Ended	3 Months Ended		6 Months Ended
	Dec. 31, 2016USD ($)	Jun. 30, 2017USD ($)	Jun. 30, 2016USD ($)	Jun. 30, 2017USD ($)	Jun. 30, 2016USD ($)
Depreciation		$ 356,329	$ 462,233	$ 759,459	$ 864,100
Loss on Disposition or Impairment [Member]
Impairment of Long-Lived Assets to be Disposed of	$ 2,400,000
Corporate Clinics [Member]
Number of Clinics Classified as Held for Sale	14

Note 4 - Property and Equipme38

Note 4 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Construction in progress	$ 139,564	$ 231,281
Property and equipment, gross	7,256,056	7,059,597
Accumulated depreciation	(3,324,119)	(2,566,172)
Property and equipment, net	4,071,501	4,724,706
Office Equipment [Member]
Property and equipment, gross	1,109,710	1,083,039
Leasehold Improvements [Member]
Property and equipment, gross	5,097,649	5,085,366
Software Development [Member]
Property and equipment, gross	1,048,697	891,192
Property Plant and Equipment, Excluding Construction in Progress [Member]
Property and equipment, net	$ 3,931,937	$ 4,493,425

Note 5 - Fair Value Considera39

Note 5 - Fair Value Consideration (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Financial Instruments, Owned, at Fair Value	$ 0	$ 0

Note 6 - Intangible Assets (Det

Note 6 - Intangible Assets (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Amortization of Intangible Assets	$ 146,897	$ 174,882	$ 321,753	$ 348,559

Note 6 - Intangible Assets - In

Note 6 - Intangible Assets - Intangible Assets Acquired (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Gross Carrying Amount	$ 3,536,000	$ 3,536,000
Accumulated Amortization	1,518,831	1,197,078
Net Carrying Value	2,017,169	2,338,922
Franchise Rights [Member]
Gross Carrying Amount	1,673,000	1,673,000
Accumulated Amortization	534,316	410,688
Net Carrying Value	1,138,684	1,262,312
Customer Relationships [Member]
Gross Carrying Amount	701,000	701,000
Accumulated Amortization	624,167	509,042
Net Carrying Value	76,833	191,958
Development Rights [Member]
Gross Carrying Amount	1,162,000	1,162,000
Accumulated Amortization	360,348	277,348
Net Carrying Value	$ 801,652	$ 884,652

Note 6 - Intangible Assets - Es

Note 6 - Intangible Assets - Estimated Amortization Expense (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
2017 (remaining)	$ 257,128
2,018	439,589
2,019	413,256
2,020	413,256
2,021	348,034
Thereafter	145,906
Total	$ 2,017,169	$ 2,338,922

Note 7 - Debt (Details Textual)

Note 7 - Debt (Details Textual)	Jan. 03, 2017USD ($)	Dec. 31, 2015USD ($)	Jun. 30, 2017USD ($)	Dec. 31, 2016USD ($)
Number of Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions		12
Revolving Credit Facility [Member]
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Line of Credit Facility, Maximum Borrowing Capacity	$ 5,000,000
Line of Credit Facility, Minimum Interest Payment Over Life of Credit Agreement	200,000
Line of Credit Facility, Periodic Payment, Interest	$ 25,000
Long-term Line of Credit			$ 1,000,000
Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member]
Debt Instrument, Face Amount		$ 800,350		$ 186,000
Debt Instrument, Interest Rate, Stated Percentage				4.25%
Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage		1.50%
Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage		5.25%

Note 7 - Debt - Maturities of N

Note 7 - Debt - Maturities of Notes Payable (Details)	Jun. 30, 2017USD ($)
2017 (remaining)	$ 100,000
Total	$ 100,000

Note 8 - Equity (Details Textua

Note 8 - Equity (Details Textual) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2013	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					190,286
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value			$ 761,049		$ 761,049
Stock Repurchased During Period, Shares		534,000
Share Price		$ 0.45
Stock Repurchased During Period, Value		$ 240,000
Treasury Stock, Retired, Cost Method, Amount		$ 791,638
Binomial Lattice-based Model, Fair Value, Share Price		$ 1.03
Binomial Lattice-based Model, Fair Value, Total		$ 551,638
Stock Issued During Period, Shares, Treasury Stock Reissued	250,872
Stock Issued During Period, Value, Treasury Stock Reissued	$ 210,000
Treasury Stock [Member]
Stock Issued During Period, Value, Treasury Stock Reissued	113,000
Common Stock [Member]
Option to Repurchase Shares, Change in Fair Value	(259,000)
Additional Paid-in Capital [Member]
Stock Issued During Period, Value, Treasury Stock Reissued	$ 162,000
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					190,286
Allocated Share-based Compensation Expense			84,845	$ 171,152	$ 135,883	$ 338,911
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options			835,077		$ 835,077
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition					2 years 146 days
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		8 years
Restricted Stock [Member]
Allocated Share-based Compensation Expense			47,211	$ 391,373	$ 91,238	$ 418,483
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 266,652		$ 266,652
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition					1 year 36 days
Minimum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price					$ 2.65
Maximum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price					$ 3.88

Note 8 - Equity - Fair Value As

Note 8 - Equity - Fair Value Assumptions of Options Granted (Details) - Employee Stock Option [Member]	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Expected volatility	42.00%
Expected dividends	0.00%	0.00%
Expected term (years) (Year)		7 years
Forfeiture rate	20.00%	0.00%
Minimum [Member]
Expected volatility		44.00%
Expected term (years) (Year)	5 years 182 days
Risk-free rate	1.98%	1.47%
Maximum [Member]
Expected volatility		45.00%
Expected term (years) (Year)	7 years
Risk-free rate	2.14%	1.68%

Note 8 - Equity - Stock Options

Note 8 - Equity - Stock Options Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Granted at Market Price, Number of Shares (in shares)	190,286
Employee Stock Option [Member]
Outstanding, Number of Shares (in shares)	953,075
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 3.66
Outstanding, Weighted Average Exercise Price (in dollars per share)	3.78	$ 3.66
Outstanding, Weighted Average Fair Value (in dollars per share)	$ 1.77	$ 1.86
Outstanding, Weighted Average Remaining Contractual Life (Year)	7 years 146 days	6 years 328 days
Exercisable, Number of Shares (in shares)	347,119
Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 4.54
Granted at Market Price, Number of Shares (in shares)	190,286
Granted at Market Price, Weighted Average Exercise Price (in dollars per share)	$ 3.69
Exercised, Number of Shares (in shares)	(69,581)
Exercised, Weighted Average Exercise Price (in dollars per share)	$ 1.20
Cancelled, Number of Shares (in shares)	(29,494)
Cancelled, Weighted Average Exercise Price (in dollars per share)	$ 5.25
Outstanding, Number of Shares (in shares)	1,044,286	953,075
Exercisable, Weighted Average Fair Value (in dollars per share)	$ 2.26
Exercisable, Weighted Average Remaining Contractual Life (Year)	4 years 292 days

Note 8 - Equity - Restricted St

Note 8 - Equity - Restricted Stock Activity (Details) - Restricted Stock [Member]	6 Months Ended
	Jun. 30, 2017shares
Unvested (in shares)	92,415
Awards granted (in shares)	59,700
Awards vested (in shares)	(74,070)
Awards forfeited (in shares)	(12,345)
Unvested (in shares)	65,700

Note 8 - Equity - Stock Repurch

Note 8 - Equity - Stock Repurchase Option (Details)	Dec. 31, 2013$ / shares
Year 1 (in dollars per share)	$ 0.56
Year 2 (in dollars per share)	0.68
Year 3 (in dollars per share)	0.84
Year 4 (in dollars per share)	1.03
Year 5 (in dollars per share)	1.28
Year 6 (in dollars per share)	1.59
Year 7 (in dollars per share)	1.97
Year 8 (in dollars per share)	$ 2.45

Note 9 - Income Taxes (Details

Note 9 - Income Taxes (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Tax Expense (Benefit)	$ 2,583	$ 73,470	$ 43,192	$ 117,867

Note 10 - Related Party Trans51

Note 10 - Related Party Transactions (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Related Party Transaction, Amounts of Transaction	$ 61,000	$ 118,000	$ 113,000	$ 310,000

Note 11 - Commitments and Con52

Note 11 - Commitments and Contingencies (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Operating Leases, Rent Expense, Net	$ 681,792	$ 854,516	$ 1,426,086	$ 1,607,011

Note 11 - Commitments and Con53

Note 11 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)	Jun. 30, 2017USD ($)
2017 (remaining)	$ 1,208,815
2,018	1,880,961
2,019	1,561,417
2,020	1,289,964
2,021	1,147,912
2,022	1,039,682
Thereafter	2,890,000
Total	$ 11,018,751

Note 12 - Segment Reporting (De

Note 12 - Segment Reporting (Details Textual)	6 Months Ended
	Jun. 30, 2017USD ($)	Jun. 30, 2016
Number of Operating Segments	2
Number of Stores	383	341
The 12 Months Ended December 31, 2016 [Member] | Reclassified from Other Unallocated Assets to Corporate Clinics Segment Assets [Member]
Prior Period Reclassification Adjustment	$ 545,000
Corporate Clinics [Member]
Number of Stores	47
Franchise Operations [Member]
Number of Stores	336

Note 12 - Segment Reporting - S

Note 12 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenues	$ 6,014,808	$ 4,974,041	$ 11,688,665	$ 9,239,077
Operating income (loss)	(984,549)	(3,186,762)	(2,571,539)	(6,667,971)
Depreciation and amortization	503,226	637,115	1,081,212	1,212,659
Other (expense) income, net	(24,030)	(1,150)	(43,496)	(677)
Loss before income tax expense	(1,008,579)	(3,187,912)	(2,615,035)	(6,668,648)
Operating Segments [Member]
Operating income (loss)	1,018,000	(634,000)	1,770,000	(1,334,000)
Corporate, Non-Segment [Member]
Operating income (loss)	(2,003,000)	(2,553,000)	(4,342,000)	(5,334,000)
Corporate Clinics [Member]
Revenues	2,680,000	2,137,000	5,176,000	3,796,000
Operating income (loss)	(438,000)	(1,647,000)	(1,037,000)	(3,336,000)
Depreciation and amortization	400,000	534,000	843,000	1,026,000
Franchise Operations [Member]
Revenues	3,335,000	2,837,000	6,513,000	5,443,000
Operating income (loss)	1,456,000	1,013,000	2,807,000	2,002,000
Depreciation and amortization
Corporate Segment [Member]
Depreciation and amortization	$ 103,000	$ 103,000	$ 238,000	$ 187,000

Note 12 - Segment Reporting -56

Note 12 - Segment Reporting - Segment Reporting Information, Assets (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016	Jun. 30, 2016	Dec. 31, 2015
Total assets	$ 16,126,156	$ 17,054,861
Unallocated cash and cash equivalents and restricted cash	3,046,777	3,009,864	$ 6,118,763	$ 16,792,850
Unallocated property and equipment	4,071,501	4,724,706
Operating Segments [Member]
Other unallocated assets	554,000	446,000
Total assets	11,612,000	12,484,000
Unallocated cash and cash equivalents and restricted cash	3,327,000	3,344,000
Unallocated property and equipment	633,000	781,000
Corporate Clinics [Member]
Total assets	9,705,000	10,481,000
Franchise Operations [Member]
Total assets	$ 1,907,000	$ 2,003,000